Abbott Laboratories (ABT) Reports Mixed Q4 Results
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $116.35 +1.94%
Financial Fact:
Interest (income): -22M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest (income): -22M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q4 EPS of $1.45, $0.01 better than the analyst estimate of $1.44. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $10.63 billion.
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
